CeriBell, Inc. (NASDAQ:CBLL) Q1 2026 Earnings Call Transcript
Operator: Thank you for standing by. At this time, I would like to welcome everyone to the Ceribell First Quarter 2026 Earnings Call. [Operator Instructions] Thank you.
Ceribell Inc. (CBLL)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Adage Capital Management Phill Gross And Robert Atchinson | 756,751 | $13,871,246 | +52% | 0.02% |
| 2. | Millennium Management Israel Englander | 552,021 | $10,118,545 | +178% | 0% |
| 3. | Royce & Associates Chuck Royce | 515,720 | $9,453,148 | -4% | 0.09% |
| 4. | Redmile Group Jeremy Green | 386,786 | $7,089,787 | -12% | 0.47% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 326,032 | $5,976,167 | +39% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.00 | 380,268 | $6,464,556.00 | 3,967,422 | 2024-10-15 | Filing | |
| $17.00 | 237,234 | $4,032,978.00 | 2,475,110 | 2024-10-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.33 | 23,554 | $431,744.82 | 816,317 | 2026-06-08 | Filing | |
| $18.33 | 1,446 | $26,505.18 | 816,317 | 2026-06-08 | Filing | |
| $18.33 | 14,000 | $256,620.00 | 816,317 | 2026-06-08 | Filing | |
| $18.00 | 1,378 | $24,804.00 | 56,291 | 2026-05-21 | Filing | |
| $18.80 | 862 | $16,205.60 | 37,751 | 2026-05-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,850,431 | $88,908,392 | 0% | |
| 2. | 3,967,422 | $72,722,845 | 1.98% | |
| 3. | 2,205,661 | $40,429,766 | 36.15% | |
| 4. | 1,813,155 | $33,235,130 | 0% | |
| 5. | 1,400,000 | $25,662,000 | 4.13% |
News See All
Ceribell (CBLL) Rose 91% after Reporting Inline Financial Results
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” fourth-quarter 2025 investor letter.
Cautious Guidance Offsets Solid Q4 for CeriBell, Inc. (CBLL), Says Canaccord
TheFly reported on February 25 that Canaccord reduced its price target for CBLL from $30 to $28 and maintained a Buy rating on the stock.
12 Most Promising Small-Cap Stocks According to Wall Street Analysts
Small-cap stocks are drawing renewed investor attention in 2026 as capital rotates away from years of concentration in mega-cap names.
CeriBell, Inc. (NASDAQ:CBLL) Q4 2025 Earnings Call Transcript
Operator: Hello, and welcome to the CeriBell, Inc. Q4 2025 Earnings Call. All lines have been placed on mute to prevent any background noise.
CeriBell, Inc. (NASDAQ:CBLL) Q3 2025 Earnings Call Transcript
Operator: Good afternoon, and thank you all for participating in today's call.
J.P. Morgan Maintains a Buy Rating on CeriBell (CBLL) With a $21 PT
CeriBell, Inc. (NASDAQ:CBLL) is one of the best medical device stocks to buy according to analysts. J.P. Morgan analyst Robbie Marcus maintained a Buy rating on CeriBell, Inc.
12 Best Medical Device Stocks to Buy According to Analysts
On July 7, CNBC’s Chery Kang and Elaine Yu talked about China’s imposition of reciprocal tariffs on the import of medical devices from the European Union.
CeriBell, Inc. (NASDAQ:CBLL) Q2 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is [ Desiree ], and I will be your conference operator today.
Transforming Neurological Care: Ceribell (CBLL)
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” first-quarter 2025 investor letter.